Noninvasive temperature monitoring for dual-modal tumor therapy based on lanthanide-doped up-conversion nanocomposites.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 30784771.
- Also identified by DOI 10.1016/j.biomaterials.2019.02.014.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Accurate treatment of photothermal therapy (PTT) is crucial to avoid the unnecessary injury of normal cells and tissues. Therefore the real-time temperature monitoring in the PTT process has drawn more and more attention in recent years. Herein, we designed and prepared one kind of lanthanide (Ln<sup>3+</sup>)-doped up-conversion nanocomposites with multi-functions, which can not only provide temperature feedback in PTT process, but also play the photodynamic therapy (PDT) function for the synergistic effect of tumor therapy. Based on NaYF<sub>4</sub>:Yb, Er up-conversion nanoparticles (UCNPs), mesoporous SiO<sub>2</sub> was modified on the surface combined with photosensitizer Chlorin e6 (Ce6) molecules, which could be excited by red emission of Er<sup>3+</sup> under the 980 nm laser. Cit-CuS NPs were further linked on the surface of the composite served as photothermal conversion agent, therefore, the temperature of the PTT site can be monitored by recording the ratio of I<sub>525</sub>/I<sub>545</sub> of green emissions, especially within the physiological range. Based on the guidance obtained from spectral experiments, we further investigated the dual-modal therapy effect both in vitro and in vivo, respectively, and acquired decent results.
Medical subject headings
- Lanthanoid Series Elements
- Nanocomposites
- Nanoparticles
- Photosensitizing Agents